Yes! My practice is one of the first in the country to offer Jeaveau NEWTOX. It was just introduced this Spring, and is rapidly becoming very popular in the facial injectable market. This is the number one aesthetic procedure in the U.S., at about $1.2 billion annually. Jeaveau
NEWTOX is injected into muscles for temporary improvement in appearance, especially of moderate to severe frown lines between the eyebrows (glabellar lines). This is the first new neurotoxin introduced in almost a decade, and the only one designed exclusively for aesthetic purposes. Most people are not aware that many of these products now used aesthetically were originally intended to provide therapeutic benefits in other areas.
I always do extensive research on any new product before I offer it, and Jeuveau NEWTOX is backed by studies with more than 2,100 patients. This includes two Phase III U.S. trials, which are solely done to answer one critical question, “Is it better than what’s already available?” Since Botox is considered the category leader, it was the largest head-to-head trial to study how NEWTOX performs versus Botox, and Jeuveau was thrilled with the results. Since patient safety is always my highest consideration, I also noted excellent results with two long-term safety studies. It is approved by the FDA.
At its core, Jeuveau NEWTOX utilizes the 900 kDa molecule, which is the gold standard in this category. But it is uniquely manufactured in a state-of-the-art facility using proprietary Hi-Pure technology for greater longevity in performance.
Please call my office or visit www.evolus.com for more information about this very exciting and promising new product.